General MedicationsORALGeneric
DEUTETRABENAZINE
DEUTETRABENAZINE
Standard Dose
12MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DEUTETRABENAZINE is listed in Drugs@FDA under application 215971 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DEUTETRABENAZINE Form and strength TABLET;ORAL - 12MG Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2024-12-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview DEUTETRABENAZINE is listed in Drugs@FDA under application 215971 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DEUTETRABENAZINE Form and strength TABLET;ORAL - 12MG Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2024-12-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.